Mevion Medical Systems has secured $150 million in financing in a deal led by YuanMing Capital and Henan Maisheng Medical Technology, both in China.
The funding will help the company clear existing debt and market its Hyperscan pencil-beam scanning technology, according to the firm.
Hyperscan is currently being used to treat patients at MedStar Georgetown University Hospital in Washington, DC. It is also being installed in two additional centers: one is a U.S. National Cancer Institute-designated center and the other is the Maastro Clinic in Maastricht, the Netherlands.
